###begin article-title 0
Complement Component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
A non-synonymous single nucleotide polymorphism (SNP) in complement component 3 has been shown to increase the risk of age-related macular degeneration (AMD). We assess its effect on AMD risk in a Northern Irish sample, test for gene-gene and gene-environment interaction, and review a risk prediction model.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 97 109 <span type="species:ncbi:9606">participants</span>
SNP  was genotyped in 1,358 samples, which comprised 437 cases, 436 no-disease controls, and 485 participants randomly sampled from the Northern Ireland population. Allele frequencies were assessed in cases and controls. Logistic regression analysis was used to assess interaction and develop a risk prediction model.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 334 337 334 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 382 388 382 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2)</italic>
###xml 414 417 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC2</italic>
###xml 445 448 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFB</italic>
We report a minor allele frequency of 0.248 for  in the population (n=485), 0.296 in cases (n=437), and 0.221 in controls (n=436; odds ratio [OR]=1.48; confidence interval [CI]: 1.19-1.85; p=0.0003). The significant association is retained following multivariate analysis with adjustment for age, smoking status, Complement Factor H (CFH), Age-Related Maculopathy Susceptibility 2 (ARMS2), Complement Component 2 (CC2), and Complement Factor B (CFB; OR=1.45; CI: 1.10-1.91; p=0.009). No evidence to support an interaction between any of the covariates within the regression model was found. The area under the receiver operator characteristic curve calculated for the fully adjusted model, including all variables, was 0.86 for late AMD.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 68 70 68 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
Our study confirmed the association between Complement Component 3 (C3) and late-stage AMD. There was no evidence for an interaction with environmental exposures, nor did we find data to support a gene-gene effect.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 930 933 930 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 936 937 936 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 938 939 938 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 966 969 966 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC2</italic>
###xml 993 996 993 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFB</italic>
###xml 999 1000 999 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 1001 1002 1001 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 1033 1035 1033 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 1038 1039 1038 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 1209 1211 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 1262 1263 1262 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 1393 1395 1393 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 1745 1747 1745 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
Age-related macular degeneration (AMD, MIM ) is a degenerative retinal disease that causes progressive impairment of the central vision and is the leading cause of irreversible severe vision loss in Caucasians over the age of 50 [1]. AMD begins with drusen formation and, in some cases, degenerative changes at the level of the retinal pigment epithelium (RPE), often referred to as early AMD, that primarily affects the macula and can progress to the visually disabling late phenotypes of geographic atrophy (GA) and/or neovascular AMD. Susceptibility to AMD is complex, involving genetic, lifestyle, and environmental factors, although the specifics of the etiology remain, in part, unresolved. Advances in our understanding of the genetic basis of the disease etiology have identified risk and protective haplotypes in several genes associated with the complement pathway and chronic inflammation, such as Complement Factor H (CFH) [2-6], Complement Component 2 (CC2)/ Complement Factor B (CFB) [7,8], and Complement Component 3 (C3) [9-11]. A dysfunctional complement pathway has been proposed to accentuate retinal cell damage with increased formation of drusen deposits, atrophy, and cell degeneration [12] and progression to choroidal neovascularization [5]. A non-synonymous single nucleotide polymorphism (SNP),  (R102G), which causes an amino acid change from arginine to glycine in C3, has been most commonly associated with late-stage AMD in other studies, primarily due to the functional nature of this variant, which differentiates between the electrophoretic allotypes of C3. As high linkage disequilibrium (LD) exists between  and  (P314L), the latter cannot be excluded as a functional variant on the basis of a genetic signal [11].
###end p 10
###begin p 11
###xml 75 83 75 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> (ARMS2)</italic>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 894 899 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MTND2</italic>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 1183 1185 1183 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 1221 1224 1221 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 1226 1231 1226 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 1233 1236 1233 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC2</italic>
###xml 1238 1241 1238 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFB</italic>
Beyond the complement pathway, the Age Related Maculopathy Susceptibility 2 (ARMS2) locus at chromosome 10q26 has been implicated as the other major genetic contributor to the AMD disease process [13-16]. Although discussion continues regarding the source of the genetic effect observed at this locus due to high LD within the region, data have been reported supporting mitochondrial involvement through interaction with the translocase of outer mitochondrial membrane proteins and co-localization to the mitochondrial-rich ellipsoid region of the photoreceptors [17,18]. Mitochondrial dysfunction and resultant increased oxidative stress have been implicated as a component of AMD disease etiology, with reports of increased mitochondrial damage in the neural retina and RPE with aging, particularly in AMD. Variation within the mitochondrial genome at NADH ubiquinone oxidoreductase chain 2 (MTND2 A4917G) has been reported to confer increased risk associated with AMD [19,20] and as such would provide an excellent biologic candidate of functional significance, although subsequent replication and validation in independent cohorts is necessary. Here, we assess the effect of the C3 functional variant  independent of CFH, ARMS2, CC2, CFB, age, and smoking status in a Northern Irish cohort; we check for potential gene-gene or gene-environment interactions, and we use the area under the receiver operator characteristic (ROC) curve to quantify the predictive ability of a logistic regression model, incorporating both genetic and environmental risk factors.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants
###end title 13
###begin p 14
###xml 973 975 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 645 657 <span type="species:ncbi:9606">participants</span>
###xml 982 994 <span type="species:ncbi:9606">participants</span>
Patients with end-stage AMD (n=437; average age=77.6 years; 39.1% male), either GA or neovascular in at least one eye were recruited opportunistically between June 2002 and September 2006 from ophthalmology clinics in the Royal Victoria Hospital, Belfast, UK, which is the regional referral center for Northern Ireland. DNA was available from an age-matched control group (n=436; average age=74.9 years; 38.5% male) recruited through random sampling of older adults (aged 65 years and above) resident in Northern Ireland and who consented to stereoscopic digital fundus photography and DNA analysis to ascertain disease status. Fundi of control participants were either free of any drusen or had fewer than five hard drusen of diameter less than 63 microm and absence of focal pigmentary irregularities, such as hyperpigmentation or hypopigmentation, with image grading undertaken by trained reading center staff using the Wisconsin Age-related Maculopathy Grading System [21]. All participants were from Northern Ireland and described themselves as of European descent. An additional control sample (n=485) obtained through random sampling of the population from across Northern Ireland in 2006 was used to assess allele frequencies only but had not been assessed for AMD disease status.
###end p 14
###begin title 15
Clinical assessment of cases
###end title 15
###begin p 16
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
###xml 164 176 <span type="species:ncbi:9606">participants</span>
###xml 253 265 <span type="species:ncbi:9606">participants</span>
###xml 374 385 <span type="species:ncbi:9606">participant</span>
###xml 872 884 <span type="species:ncbi:9606">participants</span>
Participants recruited from ophthalmology clinics had a confirmed diagnosis of late AMD made following clinical examination and fluorescein angiography [21]. In 32 participants, the diagnosis was advanced atrophic AMD, i.e., geographic atrophy, and 405 participants were diagnosed with exudative AMD. These late-stage manifestations were present in at least one eye of each participant. Cases with macular pathology due to other primary causes that mimic neovascular AMD, such as myopic degeneration, adult vitelliform, central serous retinopathy, diabetic retinopathy, or idiopathic macular telangiectasia, were excluded. Those with lens opacities sufficient to obscure retinal detail were also excluded. A history of cigarette smoking was ascertained at the time of examination, and the questionnaire used had been previously validated in the Whitehall study [22], with participants classified as never smokers, ex-smokers or current smokers.
###end p 16
###begin p 17
Informed written consent was obtained from all subjects involved. The study was approved by the Research Ethics Committee of the Queen's University of Belfast and the Office for Research Ethics Committee, Lisburn, Northern Ireland and conformed to the tenets of the Declaration of Helsinki.
###end p 17
###begin title 18
Genotyping of AMD susceptibility loci
###end title 18
###begin p 19
###xml 423 430 421 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 484 487 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 493 498 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 504 507 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC2</italic>
###xml 513 517 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFB;</italic>
###xml 526 528 524 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
DNA was extracted from peripheral blood leukocytes or frozen buffy coat samples using standard protocols in accordance with the manufacturers' instructions (Promega Wizard(R) Genomic DNA Extraction Kit, Southampton, UK). Genotyping was undertaken by multiplex PCR and primer extension methodology using standard manufacturer's protocols (ABI Snapshot, ABI, Warrington, UK) using custom-designed primer and probe sequences (Table 1) to ascertain the genetic data for , , , , , and  in CFH;  in ARMS2;  in CC2;  in CFB; and  in C3.
###end p 19
###begin title 20
Snapshot PCR primer and probe sequences
###end title 20
###begin title 21
Statistical analysis
###end title 21
###begin p 22
###xml 130 131 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 255 256 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 463 464 457 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 792 795 786 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 1467 1470 1461 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
All SNPs were verified, validated, and assessed for Hardy-Weinberg equilibrium (HWE) separately in cases and controls, using a chi2 goodness-of-fit test. Allele frequencies for the SNPs being tested were compared in cases and controls by the Pearson's chi2 test of association. The assessment of associations of genetic markers with AMD risk and interactions between genetic markers and between genetic markers and smoking were obtained using likelihood ratio chi2 tests in a logistic regression model. Age was included in the model as a continuous variable. Tests for trend for the number of risk alleles for each genetic variant (0, 1, or 2) were calculated. Initially only  was fitted in the model and additional covariates were then added to adjust for their possible confounding effect. CFH haplotypes were entered into the logistic regression model as a count (0, 1, or 2) depending on the number of copies of the haplotype an individual carried. The lowest risk haplotype was omitted from the model to avoid collinearity problems so that odds ratios (ORs) were measured relative to homozygote carriers of this haplotype. For our final risk analysis, the number of copies carried for , , and  were coded 0, 1, or 2. Tests for interactions between each of the genotypes and between genotypes and smoking were used to check for effect modification. The fitted logistic model was used to order individuals in terms of their predicted AMD risk dependent on their , CFH, , , and  genotypes and their smoking status.
###end p 22
###begin p 23
###xml 489 491 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
A value for the area under the ROC curve, also known as the C statistic, was evaluated by using only phenotypes from either end of the severity spectrum, i.e., those with symptoms of end-stage disease only and those with no features of early AMD (namely pigmentary irregularities or soft drusen deposits less than 63 mum). A method to compare the area under two ROC curves derived from paired measurements was used to assess the value of adding extra variables to the prediction equation [23].
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
Univariate analysis
###end title 25
###begin p 26
###xml 34 35 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 165 172 163 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 410 411 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 412 414 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
Genomic SNP  was assessed by a chi2 test and was found to be in HWE in both cases and controls. ORs, confidence intervals (CI), and associated p values are shown in Table 2. A minor allele frequency of 0.248 was recorded for  in the general population (n=485), and a frequency of 0.296 in cases (n=437) and 0.221 in controls (n=436; OR=1.48; CI: 1.19-1.85; p=0.0003), similar to reports from previous studies [9-11].
###end p 26
###begin title 27
Genotype and allele frequencies, odds ratios, confidence intervals (95%) and p-values for  in 437 cases of AMD and 436 controls.
###end title 27
###begin title 28
Multivariate analysis
###end title 28
###begin p 29
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2,</italic>
###xml 177 184 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC2/CFB</italic>
###xml 186 193 186 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
The significant effect associated with  was maintained after adjustment for the effects of age, cigarette smoking status, and carriage of the adverse alleles of CFH, ARMS2, and CC2/CFB (Table 3: OR=1.45; CI=1.09-1.91; p=0.009).
###end p 29
###begin title 30
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 157 164 157 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC2/CFB</italic>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
Estimates of AMD risk from a logistic regression model with terms for smoking, CFH haplotype [6], genotype at ARMS2 A69S () and the risk associated with the CC2/CFB region [8].
###end title 30
###begin p 31
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 354 360 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFHR-3</italic>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 453 456 453 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFB</italic>
###xml 461 464 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC2</italic>
###xml 472 474 472 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
Risks associated with smoking are relative to never smokers. CFH haplotypes (1-4; haplotypes 1 and 2 increase risk and are in complete LD with the C risk allele at Y402H while 3 and 4 are non-risk and in complete LD with the T allele at Y402H) are measured against haplotype 5 (the most protective haplotype, which is in complete LD with the deletion at CFHR-3) [6]. ARMS2 is measured on the heterozygosity or homozygosity of the A69S risk allele ().  (CFB),  (CC2) and  (C3) were coded as 0, 1 or 2 depending on the number of copies of the minor allele present.
###end p 31
###begin title 32
Receiver operator characteristic curves
###end title 32
###begin p 33
###xml 59 79 59 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH, ARMS2, CC2, CFB</italic>
###xml 81 83 81 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 156 164 156 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 400 402 400 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
An ROC curve for cases versus controls with the covariates CFH, ARMS2, CC2, CFB, C3, smoking status, and age fitted in the regression model is presented in Figure 1. The area under the ROC curve that was generated from the model using all covariates was 0.860 (95% CI: 0.834, 0.885; p<0.001), which showed a non-significant (p=0.22) reduction to 0.857 (95% CI: 0.831, 0.883; p<0.001) upon removal of C3.
###end p 33
###begin p 34
###xml 322 342 322 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH, ARMS2, CC2, CFB</italic>
###xml 344 346 344 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 560 562 560 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
Sensitivities and specificities for a variety of risk score cutoffs and area under the receiver operator characteristic (ROC) curve for prediction of age-related macular degeneration. The area under the ROC curve was 0.860 (95% confidence interval [CI]: 0.834-0.885; p<0.001) for cases versus controls with the covariates CFH, ARMS2, CC2, CFB, C3, smoking status, and age fitted in the regression model (solid line). The area under the ROC curve showed a non-significant reduction (dotted line; p=0.22) to 0.857 (95% CI: 0.831, 0.883; p<0.001) upon removal of C3. The dashed line represents a reference area of 0.50.
###end p 34
###begin title 35
Potential gene-gene and gene-environment interactions
###end title 35
###begin p 36
###xml 122 124 122 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 190 210 190 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH, ARMS2, CC2, CFB</italic>
Potential gene-gene and gene-environment interactions were assessed using logistic regression for all the combinations of C3 and the other parameters recorded within the full model, such as CFH, ARMS2, CC2, CFB, smoking status, and age. There was no evidence to support any interaction between the parameters measured.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 66 68 66 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 317 318 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 482 502 482 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH, ARMS2, CC2, CFB</italic>
The polymorphic variation measured for the non-synonymous SNP  in C3 shows significant association with late AMD in the Northern Irish population and supports the previously noted dose effect with an increased risk of 1.55 for heterozygotes (CI: 1.15-2.08; p=0.003) and 1.91 for homozygotes (CI: 1.11-3.30; p=0.013) [9-11]. The OR per allele copy decreases slightly from the univariate value calculated following adjustment through regression analysis for the following covariates: CFH, ARMS2, CC2, CFB, age, and smoking (OR=1.45; CI: 1.10-1.91; p=0.009). The minor allele frequency of  ascertained from the general population sample (n=485) approximates at 0.25.
###end p 38
###begin p 39
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
Considerable LD exists across this region, with the majority of investigations reporting the association observed at this locus on the basis of the genotype at  [9-11]. With evidence supporting a biologic functional effect through the formation of two common allotypes of C3 (C3F [fast] and C3S [slow]), primarily due to variation in the electrophoretic mobility, the rationale for targeting this SNP for association studies is strong [24]. However, Park et al. [11] presented data supporting extensive LD within the region and suggested that until functional data are produced supporting  as the causal variant in AMD disease etiology, it is important to consider the potential role of the non-synonymous SNP  (P314L), which is in high LD with , or indeed the potential role of any additional and as yet undetermined variants that may also be in complete LD.
###end p 39
###begin p 40
###xml 128 136 128 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 314 317 314 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARMS2</italic>
###xml 334 337 334 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC2</italic>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFB;</italic>
###xml 356 358 356 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 817 820 817 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 856 857 856 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 1148 1149 1148 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1295 1302 1295 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFHR1&#8211;3</italic>
###xml 1600 1602 1600 1602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 2284 2286 2284 2286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
Inclusion of  as a variable has helped refine our AMD disease prediction model, providing an area under the ROC curve of 0.860 (Figure 1). Seddon et al. [25] reported an ROC curve of 0.831 in a longitudinal study of progression to advanced AMD, using a model incorporating information on the genetic loci  and  in CFH;  in ARMS2;  in CC2;  in CFB; and  in C3 in addition to the response to therapeutic supplementation. Our ROC area was comparable to that of Seddon et al. [25], despite the cross-sectional nature of our study. The similarity of the values determined from this study to that reported by Seddon et al. [25] may be due to the homogeneity of our sample in terms of the late-stage disease phenotype, which could have contributed to an improved ROC area. Also, we used an informative representation of the CFH locus identifying five haplotypes [6] as opposed to the binary format of the Y402H locus, which is used in most investigations. Although Seddon et al. [25] used two SNPs, offering improved power over Y402H alone, we contend that there is merit in using the haplotypic structure of this locus, which improved the ROC statistic [6]. This haplotype is based upon several SNPs from this region, which enable the differentiation of five haplotypes, including the deletion at the CFHR1-3 locus. It was interesting to note that addition of  within our regression model did not significantly improve the area under the ROC curve, with only a moderate increase from 0.857 to 0.860. Evaluation of risk prediction models requires model performance measures, such as the popular ROC metric [23]. Its probabilistic interpretation is based upon the ability of the models' predicted probabilities to correctly discriminate between randomly selected diseased and nondiseased subjects. However, it is known that the area under the ROC curve often shows only small and nonsignificant improvements, even for a predictor variable that makes a significant independent contribution in a logistic regression analysis. More recently, alternative methods for evaluating the usefulness of a new marker have been proposed, such as event-specific reclassification tables and integrated (average) sensitivity, although these methodologies are more useful in cohort than case-control studies [26].
###end p 40
###begin p 41
###xml 19 21 19 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C3</italic>
In conclusion, the C3 locus has a small but significant role in the etiology of the disease process of AMD in comparison to the other established genetic risk factors. Smoking and the genetic risk factors were found to exert an independent effect in this cohort study. While this conclusion supports the findings of other independent investigations, reports have been published supporting gene-gene or gene-environment interactions in AMD. Perhaps it would be appropriate to exercise caution in defining interaction on the basis of single studies but implementation of replication in independent data sets in a manner similar to that required for purely genetic association studies would provide a more robust measure.
###end p 41
###begin p 42
Our findings add to the literature on calculating AMD risk and could, in time, facilitate earlier practical intervention for those at risk, with either lifestyle modification strategies or preclinical therapeutic intervention when these become available. These models will also enable us to identify predicted high-risk individuals who are aged and have not progressed to a severe disease phenotype or, conversely, individuals with low predicted risk and disease, for inclusion within future studies for elucidating novel risk factors that contribute to the AMD disease process.
###end p 42
###begin title 43
Acknowledgments
###end title 43
###begin p 44
###xml 180 184 <span type="species:ncbi:9615">Dogs</span>
The authors are indebted to those who have participated in this study. We thank Evelyn Moore and Vittorio Silvestri for technical assistance. This research was funded by The Guide Dogs for the Blind Association UK (2008-5a); Research and Development Office, Northern Ireland Health and Personal Social Services (RRG 4.5); EVI-GENORET, an integrated project funded through the European Union Research Project (FP6).
###end p 44
###begin title 45
References
###end title 45
###begin article-title 46
###xml 64 71 <span type="species:ncbi:9606">persons</span>
Prevalence of visual impairment and selected eye diseases among persons aged >/= 50 years with and without diabetes- United States, 2002.
###end article-title 46
###begin article-title 47
Complement factor H polymorphism in age-related macular degeneration.
###end article-title 47
###begin article-title 48
Complement factor H variant increases the risk of age-related macular degeneration.
###end article-title 48
###begin article-title 49
Complement factor H polymorphism and age-related macular degeneration.
###end article-title 49
###begin article-title 50
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.
###end article-title 50
###begin article-title 51
az-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.
###end article-title 51
###begin article-title 52
AMD Genetics Clinical Study Group, Hageman GS, Dean M, Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.
###end article-title 52
###begin article-title 53
Further assessment of the Complement Component 2 and Factor B region associated with Age-related Macular Degeneration.
###end article-title 53
###begin article-title 54
Complement C3 variant and the risk of age-related macular degeneration.
###end article-title 54
###begin article-title 55
Variation in complement factor 3 is associated with risk of age-related macular degeneration.
###end article-title 55
###begin article-title 56
Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration.
###end article-title 56
###begin article-title 57
A role for local inflammation in the formation of drusen in the aging eye.
###end article-title 57
###begin article-title 58
Susceptibility genes for age-related maculopathy on chromosome 10q26.
###end article-title 58
###begin article-title 59
###xml 13 22 13 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.
###end article-title 59
###begin article-title 60
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
HTRA1 promoter polymorphism in wet age-related macular degeneration.
###end article-title 60
###begin article-title 61
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.
###end article-title 61
###begin article-title 62
###xml 35 50 35 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715/ARMS2</italic>
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration.
###end article-title 62
###begin article-title 63
Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA.
###end article-title 63
###begin article-title 64
Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration.
###end article-title 64
###begin article-title 65
Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration.
###end article-title 65
###begin article-title 66
The Wisconsin age-related maculopathy grading system.
###end article-title 66
###begin article-title 67
Smoking and other risk factors for coronary heart disease.
###end article-title 67
###begin article-title 68
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.
###end article-title 68
###begin article-title 69
###xml 36 41 <span type="species:ncbi:9606">human</span>
Molecular basis of polymorphisms of human complement component C3.
###end article-title 69
###begin article-title 70
Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.
###end article-title 70
###begin article-title 71
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.
###end article-title 71

